Proteon logo     Print Page | Close Window

SEC Filings

4
DEERFIELD MANAGEMENT CO filed this Form 4 on 12/04/2017
Entire Document
 

 

Joint Filer Information

 

Names:

Deerfield Mgmt, L.P., Deerfield Management Company, L.P.,

Deerfield International Master Fund, L.P., Deerfield Partners, L.P.

   
Address:

780 Third Avenue, 37th Floor

New York, NY  10017

   
Designated Filer: James E. Flynn
   
Issuer and Ticker Symbol: Proteon Therapeutics, Inc.  [PRTO]
   
Date of Event Requiring Statement:  November 30, 2017

 

The undersigned, Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield International Master Fund, L.P. and Deerfield Partners, L.P., are jointly filing the attached Statement of Changes in Beneficial Ownership on Form 4 with James E. Flynn with respect to the beneficial ownership of securities of Proteon Therapeutics, Inc.

 

Signatures:

 

DEERFIELD MGMT, L.P.

 

By: J.E. Flynn Capital, LLC, General Partner

 

By: /s/ Jonathan Isler

       Jonathan Isler, Attorney-In-Fact

 

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

 

By: Deerfield Mgmt, L.P., General Partner

 

By: J.E. Flynn Capital, LLC, General Partner

 

By: /s/ Jonathan Isler

       Jonathan Isler, Attorney-In-Fact

 

DEERFIELD MANAGEMENT COMPANY, L.P.

 

By: Flynn Management LLC, General Partner

 

By: /s/ Jonathan Isler

       Jonathan Isler, Attorney-In-Fact

 

DEERFIELD PARTNERS, L.P.

 

By: Deerfield Mgmt, L.P., General Partner

 

By: J.E. Flynn Capital, LLC, General Partner

 

By: /s/ Jonathan Isler

       Jonathan Isler, Attorney-In-Fact